These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23023324)

  • 1. Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenografts.
    Sirvent A; Vigy O; Orsetti B; Urbach S; Roche S
    Mol Cell Proteomics; 2012 Dec; 11(12):1937-50. PubMed ID: 23023324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.
    Leroy C; Fialin C; Sirvent A; Simon V; Urbach S; Poncet J; Robert B; Jouin P; Roche S
    Cancer Res; 2009 Mar; 69(6):2279-86. PubMed ID: 19276381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approach].
    Sirvent A; Urbach S; Roche S
    Med Sci (Paris); 2014 May; 30(5):558-66. PubMed ID: 24939544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of targets of c-Src tyrosine kinase by chemical complementation and phosphoproteomics.
    Ferrando IM; Chaerkady R; Zhong J; Molina H; Jacob HK; Herbst-Robinson K; Dancy BM; Katju V; Bose R; Zhang J; Pandey A; Cole PA
    Mol Cell Proteomics; 2012 Aug; 11(8):355-69. PubMed ID: 22499769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
    Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
    J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRC activates TAZ for intestinal tumorigenesis and regeneration.
    Byun MR; Hwang JH; Kim AR; Kim KM; Park JI; Oh HT; Hwang ES; Hong JH
    Cancer Lett; 2017 Dec; 410():32-40. PubMed ID: 28939028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
    Tian Q; Yuan P; Quan C; Li M; Xiao J; Zhang L; Lu H; Ma T; Zou L; Wang F; Xue P; Ni X; Wang W; Liu L; Wang Z; Zhu F; Duan Q
    Oncogene; 2020 May; 39(20):3980-3996. PubMed ID: 32238881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling.
    Amanchy R; Zhong J; Hong R; Kim JH; Gucek M; Cole RN; Molina H; Pandey A
    Mol Oncol; 2009 Dec; 3(5-6):439-50. PubMed ID: 19632164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
    Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
    Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays.
    Amanchy R; Zhong J; Molina H; Chaerkady R; Iwahori A; Kalume DE; Grønborg M; Joore J; Cope L; Pandey A
    J Proteome Res; 2008 Sep; 7(9):3900-10. PubMed ID: 18698806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.
    Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT
    J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors.
    Franco M; Furstoss O; Simon V; Benistant C; Hong WJ; Roche S
    Mol Cell Biol; 2006 Mar; 26(5):1932-47. PubMed ID: 16479011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global impact of oncogenic Src on a phosphotyrosine proteome.
    Luo W; Slebos RJ; Hill S; Li M; Brábek J; Amanchy R; Chaerkady R; Pandey A; Ham AJ; Hanks SK
    J Proteome Res; 2008 Aug; 7(8):3447-60. PubMed ID: 18563927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.
    Cunningham DL; Sweet SM; Cooper HJ; Heath JK
    J Proteome Res; 2010 May; 9(5):2317-28. PubMed ID: 20225815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).
    Amanchy R; Kalume DE; Iwahori A; Zhong J; Pandey A
    J Proteome Res; 2005; 4(5):1661-71. PubMed ID: 16212419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PZR promotes metastasis of colorectal cancer through increasing FAK and Src phosphorylation.
    Tan D; Zhang W; Tao Y; Galiya Y; Wang M
    Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):356-364. PubMed ID: 30877754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway.
    Sun W; Wang X; Li J; You C; Lu P; Feng H; Kong Y; Zhang H; Liu Y; Jiao R; Chen X; Ba Y
    Cell Death Dis; 2018 Apr; 9(4):438. PubMed ID: 29739921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 5'-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I.
    Prasad N; Topping RS; Decker SJ
    J Cell Sci; 2002 Oct; 115(Pt 19):3807-15. PubMed ID: 12235291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
    Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
    Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 controls Src/STAT3 activity in human tumors.
    Bretz NP; Salnikov AV; Perne C; Keller S; Wang X; Mierke CT; Fogel M; Erbe-Hofmann N; Schlange T; Moldenhauer G; Altevogt P
    Cell Mol Life Sci; 2012 Nov; 69(22):3863-79. PubMed ID: 22760497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.